FdaApplication
BLA 125614
Identifiers
- fda_app_no: BLA125614
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline Biologicals |
| application_type | BLA |
| approval_date | 2017-10-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SHINGRIX | — | 50UG | For Injection |
| SHINGRIX | — | 0.5ML | Injection |
| SHINGRIX | — | 50UG | Injection |
3 products